MedPath

Comparison of the effect of norepinephrine with and without dobutamine on mortality and morbidity of children with septic shock

Phase 2
Recruiting
Conditions
Septic shock.
Postprocedural septic shock
T81.12
Registration Number
IRCT20101220005426N13
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Children in the age group of 2 to 14 years
Children with septic shock
They need to transfer to the intensive care unit

Exclusion Criteria

Children with organ failure
The patient's lack of consent, or if the patient is unable to answer, the patient's guardian's lack of consent
The presence of heart failure, kidney and diabetes

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemodynamic and blood supply findings (CO-MAP-HR). Timepoint: Measuring CO-MAP-HR at the beginning of the study (before the intervention) and then every hour until the end of the study. Method of measurement: Ecocardiography.;Vasopressor dependence days. Timepoint: The number of days that patients receive vasopressor. Method of measurement: Check list.;Urinary tract. Timepoint: At the beginning of the study and then every 6 hours until the end of the study. Method of measurement: Check list.;Duration of hospitalization in the intensive care unit. Timepoint: At the beginning of the study and then daily until the end of hospitalization in the relevant department. Method of measurement: Check list.;Serum lactate level. Timepoint: At the beginning of the study, then daily until the end of the study. Method of measurement: AutoAnalyzer.;Electrolytes (urea, creatinine). Timepoint: At the beginning of the study, then daily until the end of the study. Method of measurement: AutoAnalyzer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath